¼¼°èÀÇ ÀڱñÙÁ¾(UF) Ä¡·á ±â±â ½ÃÀå(2025-2029³â)
Global Uterine Fibroid (UF) Treatment Device Market 2025-2029
»óǰÄÚµå : 1723094
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 213 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,443,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,508,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀڱñÙÁ¾(UF) Ä¡·á ±â±â ½ÃÀåÀº 2024-2029³â¿¡ 33¾ï 5,820¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø±â°£ Áß CAGRÀº 9.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀڱñÙÁ¾(UF) Ä¡·á ±â±â ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀڱñÙÁ¾ À¯º´·ü Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡, ÀڱñÙÁ¾ Ä¡·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ¿¬µµ 2025
Á¾·á¿¬µµ 2029
¿¹Ãø ±â°£ 2025-2029
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 2025³â 8.8%
CAGR 9.6%
Áõ°¡¾× 33¾ï 5,820¸¸ ´Þ·¯

º» Á¶»ç´Â ¾÷°èÀÇ ÁÖ¿ä Âü°¡ÀڷκÎÅÍÀÇ ÀÎDzÀ» Æ÷ÇÔÇÑ 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸ÀÇ °´°üÀûÀÎ Á¶ÇÕÀ» »ç¿ëÇÏ¿© ½ÃÇàÇß½À´Ï´Ù. ¸®Æ÷Æ®¿¡´Â ÁÖ¿ä ±â¾÷ÀÇ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀû ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ ÀÇÇÑ ºÎ¹®, º¥´õ ±¸µµ°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ¸®Æ÷Æ®¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÇâÈÄ ¼ö³â°£ ÀڱñÙÁ¾(UF) Ä¡·á ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î ½ÅÈï ±¹°¡ÀÇ ÀÇ·á ½Ã½ºÅÛ °³¼±À» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ Àúħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿Í ÷´Ü ±â¼úÀÇ Ã¤Åà Ȯ´ë°¡ ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Technavio ºÐ¼®

Á¦3Àå ½ÃÀå ±¸µµ

Á¦4Àå ½ÃÀå ±Ô¸ð

Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦6Àå Á¤¼º ºÐ¼®

Á¦7Àå Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : Ä¡·á ¿µ¿ªº°

Á¦9Àå ½ÃÀå ¼¼ºÐÈ­ : ±â¼úº°

Á¦10Àå ½ÃÀå ¼¼ºÐÈ­ : ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå °í°´ »óȲ

Á¦12Àå Áö¿ªº° »óȲ

Á¦13Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå °æÀï ºÐ¼®

Á¦16Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The uterine fibroid (UF) treatment device market is forecasted to grow by USD 3358.2 mn during 2024-2029, accelerating at a CAGR of 9.6% during the forecast period. The report on the uterine fibroid (UF) treatment device market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of uterine fibroids, increase in healthcare expenditure, and growing awareness about uterine fibroid treatment.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20258.8%
CAGR9.6%
Incremental Value$3358.2 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's uterine fibroid (UF) treatment device market is segmented as below:

By Therapeutic Area

By Technology

By End-user

By Geographical Landscape

This study identifies the improving healthcare systems in emerging economies as one of the prime reasons driving the uterine fibroid (UF) treatment device market growth during the next few years. Also, increasing preference for minimally invasive procedures and growing adoption of advanced technologies will lead to sizable demand in the market.

The report on the uterine fibroid (UF) treatment device market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading uterine fibroid (UF) treatment device market vendors that include AbbVie Inc., Boston Scientific Corp., Chongqing Haifu Medical Technology Co. Ltd., Conmed Corp., CooperSurgical Inc., Hologic Inc., INSIGHTEC Ltd., KARL STORZ SE and Co. KG, Lumenis Be Ltd., Medtronic Plc, Merit Medical Systems Inc., Minerva Surgical Inc., Olympus Corp., Profound Medical Corp., and Stryker Corp.. Also, the uterine fibroid (UF) treatment device market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Therapeutic Area

9 Market Segmentation by Technology

10 Market Segmentation by End-user

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â